王亚萍，女，医学博士，副研究员，硕士研究生导师，2013年至今于广州医科大学附属市八医院肝病科和感染科从事临床、科研、教学工作。主要围绕“干扰素实现乙肝功能治愈机制”开展基础及临床应用研究，主持广东省省自然科学基金2项，市校（院）联合资助面上项目1项，参与国家自然科学基金面上项目、十三五传染病重大专项研究及广州实验室多项新冠课题基金项目。近三年来，以第一作者或共同一作在Cellular & Molecular Immunology、Nature Communications、EClinicalMedicine上发表论文多篇。国家实用新型专利发明人2项。
学术任职：广东省医师协会肝病专科医师分会委员，广东省器官医学与技术学会肝脏医学与技术专业委员会委员，广州市医师协会青年医师分会委员，广东省医学教育协会肝病专业委员会委员
研究方向：慢乙肝功能性治愈
招生专业：内科学（感染病），学术临床学位
联系方式：xiruo0833@sina.com
代表性论文如下：
1. Yaping Wang; Liliangzi Guo; Jingrong Shi; Jingyun Li; Yanling Wen; Guoming Gu; Jianping Cui; Chengqian Feng; Mengling Jiang; Qinghong Fan; Jingyan Tang; Sisi Chen; Jun Zhang; Xiaowen Zheng; Meifang Pan; Xinnian Li; Yanxia Sun; Zheng Zhang; Xian Li; Fengyu Hu; Liguo Zhang; Xiaoping Tang; Feng Li ; Interferon stimulated immune profile changes in a humanized mouse model of HBV infection, Nature Communications, 2023, 14(1): 1058-1071
2. Yaping wang; Ruchong Chen; Fengyu Hu; Yun Lan; Zhaowei Yang; Chen Zhan; Jingrong shi; Xizi Deng; Mei Jiang; Shuxin Zhong; Baolin Liao; Kai Deng; Jinyan Tang; Liliangzi Guo; Mengling Jiang; Qinghong Fan; Meiyu Li; Jinxin Liu; Yaling Shi; Xilong Deng; Xincai Xiao; Ming Kang; Yan Li; Weijie Guan; Yimin Li; Shiyue Li; Feng ui; Nanshan Zhong; Xiaoping Tang ; Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC inGuangzhou, China, eClinicalMedicine, 2021, 40: 0-101129
3. Hu, Fengyu; Chen, Fengjuan; Ou, Zhihua; Fan, Qinghong; Tan, Xinghua; Wang, Yaping; Pan, Yuejun; Ke, Bixia; Li, Linghua; Guan, Yujuan; Mo, Xiaoneng; Wang, Jian; Wang, Jinlin; Luo, Chun; Wen, Xueliang; Li, Min; Ren, Peidi; Ke, Changwen; Li, Junhua; Lei, Chunliang; Tang, Xiaoping; Li, Feng ; A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract, Cellular and Molecular Immunology, 2020, 17(11): 1119-1125 （共同一作)
4. Feng, C; Shi, J; Fan, Q; Wang, YW; Huang, H; Chen, F; Tang, G; Li, Y; Li, P; Li, J; Cui, J; Guo, L; Chen, S; Jiang, M; Feng, L; Chen, L; Lei, C; Ke, C; Deng, X; Hu, F; Tang, X; Li, Nature communications ; Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery, Nature Communications, 2021, 12(1): 0-4984 (共同一作)
5. Haisheng Yu; Banghui Liu; Yudi Zhang; Xijie Gao; Qian Wang; Haitao Xiang; Xiaofang Peng; Caixia Xie; Yaping Wang; Peiyu Hu; Jingrong Shi; Quan Shi; Pingqian Zheng; Chengqian Feng; Guofang Tang; Xiaopan Liu; Liliangzi Guo; Xiumei Lin; Jiaojiao Li; Chuanyu Liu; Yaling Huang; Naibo Yang; Qiuluan Chen; Zimu Li; Mengzhen Su; Qihong Yan; Rongjuan Pei; Xinwen Chen; Longqi Liu; Fengyu Hu; Dan Liang; Bixia Ke; Changwen Ke; Feng Li; Jun He; Meiniang Wang; Ling Chen; Xiaoli Xiong; Xiaoping Tang ; Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants, Nature Communications, 2023, 14(1): 1058-1071 (共同一作）
6. Wang, Y; Liao, B; Guo, Y; Li, F; Lei, C; Zhang, F; Cai, W; Hong, W; Zeng, Y; Qiu, S; Wang , J; Li, Y; Deng, X; Li, J; Xiao, G; Guo, F; Lai, X; Liang, Z; Wen, X; Li, P; Jiao, Q; Xiang, F; Wang, Y; Ma, C; Xie, Z; Lin, W; Wu, Y; Tang, X; Li, L; Guan, Y ; Clinical Characteristics of Pati ents Infected With the Novel 2019 Coronavirus (SARS-Cov-2) in Guangzhou, China, Open Forum Infect Dis, 2020, 7(6): 0-ofaa187.
7. Wang, YW; Deng, K. ; Environmental Risk Factors for Talaromycosis Hospitalizations of HIV-Infected Patients in Guangzhou, China: Case Crossover Study, Front Med (Lausanne), 2021, 8(0): 0-731188
